abstract |
In certain aspects, the present invention provides a method of administering an activin-ActRIIa antagonist to a patient, and a method of managing a patient treated with an activin-ActRIIa antagonist. In certain aspects, these methods involve measuring one or more hematological parameters in a patient. |